The manifesto, launched by the trade association for the research-based pharmaceutical industry in Sweden (Lif), includes nine commitments that covers the entire value chain of medicines, from research and development
Nordic Life Science
Pharma news from the Nordic life science industry
Latest news
Immunicum has been granted an Orphan Drug Designation (ODD) for ilixadencel in the treatment of Gastrointestinal Stromal Tumors (GIST). This designation confirms the need and potential for ilixadencel as a
The Board of Directors of Spago Nanomedical has resolved to carry out a rights issue with preferential rights for existing shareholders of up to 61.8 MSEK before issue costs. Four
Immedica Pharma and Japanese company OrphanPacific entered an agreement under which OrphanPacific gains the exclusive rights to Ravicti in Japan. The pharmaceutical drug product Ravicti is approved in Europe and
Capitainer has closed a share issue to capitalize on growing interest in home-sampling with its new qDBS dried blood spot testing system. The investment round, led by Sciety, brought in
Orion Corporation has entered into an agreement with Chinese Jemincare, through which Orion will receive exclusive global development and commercialization rights, excluding the Greater China area (mainland China, Hong Kong,
Calliditas Therapeutics has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the granting of a conditional
The Rhode Island Department of Health has granted Immunovia, Inc., the US subsidiary of Immunovia, Clinical Laboratory licensure. The licensure allows physicians in Rhode Island to order the IMMray PanCan-d
Nordic Biomarker is partnering with private equity company Procuritas. ”Together with our new Swedish majority owner Procuritas, who share our vision for the company to become a leading global supplier
BICO has acquired all the shares in San Diego-based Allegro 3D for an up-front enterprise value of USD 6 million. Additionally, the shareholders can receive USD 5 million in an
The two companies have announced a collaboration to create a portfolio of novel research programmes to develop transformational medicines. The collaborators will explore opportunities to apply Flagship’s bioplatforms, an ecosystem
Clinical trials
The prosecutors in the Paolo Macchiarini trial asked the court on Monday for at least five years in prison for the surgeon. Macchiarini went on trial April 27 in Sweden
AlzeCure Pharma has received approval from the regulatory authorities in Sweden to initiate its clinical phase IIa study with the drug candidate ACD440 in patients with peripheral neuropathic pain. ”We
Gedea Biotech has received regulatory approval from the Ethics Committee and the Swedish Medical Products Agency and will start the EpHect clinical study of its lead product, pHyph, a vaginal
EpiEndo Pharmaceuticals has completed its Phase I First Time in Human (FTIH) study with EP395 in healthy subjects. EP395 is the first of EpiEndo’s orally available, non-antibiotic macrolides or ‘Barriolides’
Immunicum has announced updated interim results from the ongoing ADVANCE II clinical trial evaluating the company’s lead development program DCP-001, a novel therapeutic option for acute myeloid leukemia (AML) maintenance
BioInvent International has announced its novel anti-FcyRIIB antibody BI-1206 is progressing into the expansion phase of a Phase 1/2a trial for non-Hodgkin’s lymphoma (NHL), following a positive End-of-Phase 1 meeting
Targovax has entered into a clinical trial collaboration agreement with Oslo University Hospital (OUS) to run a phase 1/2 study testing polyvalent mutant RAS vaccine TG01 in multiple myeloma (MM)
Nykode Therapeutics has announced positive interim results from its Phase 2 VB C-02 trial of VB10.16, its wholly-owned therapeutic cancer vaccine, in combination with the PD-L1 inhibitor atezolizumab in patients
Cyxone has announced results from its ongoing collaboration with Medical University of Vienna. Cyxone and its research partner, the Medical University of Vienna, announced pre-clinical data further supporting T20K as
Sustainability
A new study by an international consortium, including researchers from Stockholm University, looking at the presence of pharmaceuticals in the world’s rivers, found concentrations at potentially toxic levels in more
CDMO Recipharm has announced that its 2020 International Environmental Award will be presented to Amy Pruden, Professor of Civil and Environmental Engineering at Virginia Tech in Blacksburg, Virginia, US. Amy
The professorship at the University of Helsinki, which is being established with the support of a fund, is aimed at strengthening sustainable development expertise in pharmacy across the globe. The
IVL Swedish Environmental Research Institute and Simrishamn Municipality have tested a completley new treatment system that has now been added to the Stengården sewage plant in Simrishamn, Sweden. “Removing pharmaceutical
Nordic efforts to prevent pharmaceuticals affecting the environment include Danish management of hospital wastewater and a Swedish large-scale sewage plant for removal of pharmaceutical residues. Wastewater from hospitals can contain